Ardelyx real-world study shows phosphate reductions after Xphozah initiation in dialysis patients
ARDX•Ardelyx presented real-world results showing lower serum phosphate levels over six months after Xphozah initiation in more than 1,400 adults on dialysis.
1. Study results
The analysis found phosphate reductions across evaluated groups, including patients taking Xphozah without phosphate binders or alongside a single binder. Ardelyx presented the results at ASN Kidney Week 2026.
